BIT
KDNY

BlackRock Institutional Trust’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

BlackRock Institutional Trust’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$8.86M Buy
155,485
+31,116
+25% +$1.88M ﹤0.01% 2461
2016
Q3 		$7.73M Buy
124,369
+22,012
+22% +$1.56M ﹤0.01% 2495
2016
Q2 		$5.79M Buy
102,357
+58,453
+133% +$3.55M ﹤0.01% 2608
2016
Q1 		$2.81M Sell
43,904
-332
-0.8% -$26.9K ﹤0.01% 2907
2015
Q4 		$6.22M Buy
44,236
+99
+0.2% +$13.4K ﹤0.01% 2595
2015
Q3 		$4.28M Buy
44,137
+31,305
+244% +$3.73M ﹤0.01% 2794
2015
Q2 		$1.95M Buy
+12,832
New +$2.12M ﹤0.01% 3131

Other funds holding KDNY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

BlackRock Institutional Trust's KDNY Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Chinook Therapeutics, Inc. Common Stock (KDNY) stake by 25% in Q4 2016, buying an estimated $1.88M and bringing the position to 155,485 shares worth $8.86M. The position accounts for ﹤0.01% of the portfolio, ranked #2461.

BlackRock Institutional Trust first reported a position in KDNY in Q2 2015 and has held it in 7 quarters since. 87 funds tracked by Wall St. Rank hold KDNY as of Q4 2016.

  • BlackRock Institutional Trust held 155,485 shares of Chinook Therapeutics, Inc. Common Stock worth $8.86M as of Q4 2016.
  • BlackRock Institutional Trust bought 31,116 Chinook Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $1.88M.
  • Chinook Therapeutics, Inc. Common Stock made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2461 holding.
  • BlackRock Institutional Trust first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and has held it in 7 quarters since.
  • 87 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.